Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
01/18/2012 | EP1360957B1 Vitamin/mineral complex |
01/18/2012 | CN202113359U Fat reducing capsule |
01/18/2012 | CN202112319U Weight-losing and body-slimming waistband |
01/18/2012 | CN102321626A Means for inhibiting the expression of protein kinase 3 |
01/18/2012 | CN102321239A Preparation method of water-soluble toluylene compound prodrugs |
01/18/2012 | CN102321170A Liraglutide variant and conjugate thereof |
01/18/2012 | CN102321129A Stilbene glycoside injection and preparation process thereof |
01/18/2012 | CN102321024A Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof |
01/18/2012 | CN102321023A Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
01/18/2012 | CN102321020A LXR receptor modulators |
01/18/2012 | CN102321019A Crystal form of quinoline compound and process for its production |
01/18/2012 | CN102321014A Novel di-phenylpyridine derivative |
01/18/2012 | CN102320956A Sodium ferulate composition freeze-dried powder injection and preparation method thereof |
01/18/2012 | CN102319422A Long - acting formulations of insulins |
01/18/2012 | CN102319421A Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
01/18/2012 | CN102319417A Moderating the effect of endotoxins |
01/18/2012 | CN102319402A Chinese medicinal natural weight-reducing medicament for conditioning whole bodies |
01/18/2012 | CN102319383A Traditional Chinese medicine for treating diabetic diarrhea |
01/18/2012 | CN102319364A Manufacturing method of dendrobium candidum wallex lindll pure powder tablets |
01/18/2012 | CN102319357A Lipid-lowering dispersible tablets and preparation technology thereof |
01/18/2012 | CN102319341A Chinese medicinal compound for treating and preventing diabetes |
01/18/2012 | CN102319327A Traditional Chinese medicine for internally and externally treating diabetic foot |
01/18/2012 | CN102319300A Method for extracting total saponins from beesia calthaefolia medicinal material |
01/18/2012 | CN102319289A Hyperglycemic Chinese medicinal composition comprising cinnamon polyphenol and the like and preparation method of hyperglycemic Chinese medicinal composition |
01/18/2012 | CN102319278A Monascus compound preparation capable of regulating pressure and lipid and improving arteriosclerosis, coronary heart disease and cerebral embolism |
01/18/2012 | CN102319275A Sunset abelmoschus flower extract, preparation and preparation method thereof |
01/18/2012 | CN102319273A Salicornia biggelowii Torr. active total saponin extract, its preparation method and its purpose of losing weight |
01/18/2012 | CN102319266A krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
01/18/2012 | CN102319263A Film coated tablets containing a plurality of vitamins and mineral matters, and its preparation process |
01/18/2012 | CN102319262A 5% glucose child nutrient solution and preparation method thereof |
01/18/2012 | CN102319259A 5% glucose adult nutrient solution and preparation method thereof |
01/18/2012 | CN102319258A 5 percent glucose substitution liquid and preparation method thereof |
01/18/2012 | CN102319256A Application of porphyra polysaccharide in preparing treatment medicament or prevention health-care product of kidney diseases |
01/18/2012 | CN102319245A Composition containing repaglinide and metformin hydrochloride and preparation thereof |
01/18/2012 | CN102319236A Application of polygonatum homoisoflavonoid compound in preparing product for treating diabetes mellitus and nephropathy |
01/18/2012 | CN102319216A Insulin liposome lyophilized powder, oral insulin compound preparation and preparation methods and applications thereof |
01/18/2012 | CN102319192A Enzyme bathing material for clearing toxins of human body and preparation method thereof |
01/18/2012 | CN101884611B Method for preparing medicinal invert sugar by sugar hydrolysis |
01/18/2012 | CN101863871B Total glycosides of Rhodiola rosea, medical application and preparation method thereof |
01/18/2012 | CN101862413B Chinese medicinal preparation for treating type-2 diabetes and preparation method thereof |
01/18/2012 | CN101810665B Use of yuenkanin organic acid for preparing weight-losing and blood lipid-lowering medicine |
01/18/2012 | CN101810664B Use of yuenkanin total saponins for preparing weight-losing and blood lipid-lowering medicine |
01/18/2012 | CN101804089B Use of total flavonoids from radix Daphne genkwa in preparing weight-losing hypolipemic drugs |
01/18/2012 | CN101712669B Method for separating and purifying luteolin |
01/18/2012 | CN101695487B Polyenoic ethyl ester emulsion of high-purity EPA-E and DHA-E |
01/18/2012 | CN101607080B Oral drug for treating diabetes and preparation method thereof |
01/18/2012 | CN101524493B Multifunctional Chinese medicine honeyed pill |
01/18/2012 | CN101396482B Traditional Chinese medicine preparation for treating diabetes |
01/18/2012 | CN101380110B Nutritive composition with iron replenishing function and preparation method thereof |
01/18/2012 | CN101327198B Thiazolidinedione metallic salt medicament enteric-coated formulation and preparation method thereof |
01/18/2012 | CN101278919B Metformin hydrochloride and Glipizide sustained-release pellet and method of preparing the same |
01/18/2012 | CN101238123B Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehyftogenase type I |
01/18/2012 | CN101087754B Novel cyclohexane derivatives |
01/17/2012 | US8097643 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
01/17/2012 | US8097640 Prophylactic or therapeutic agent for diabetic maculopathy |
01/17/2012 | US8097620 Diazaquinolones that inhibit prolyl hydroxylase activity |
01/17/2012 | US8097617 Organic compounds |
01/17/2012 | US8097587 IGF-I protein variants for treating IGFBP-1-related disorders |
01/17/2012 | US8097279 Chewable soft capsule |
01/17/2012 | US8097262 Gel type enteral nutrient |
01/17/2012 | CA2559611C Pyrrolidine compounds |
01/17/2012 | CA2517390C Chroman-derived anti-androgens for treatment of androgen-mediated disorders |
01/17/2012 | CA2500873C Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
01/17/2012 | CA2484269C Compounds and method for coating surfaces in a haemocompatible manner |
01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
01/17/2012 | CA2413195C Ligand to gpr8 and dna thereof |
01/17/2012 | CA2379180C Methods for suppressing appetite and enhancing exercise and recovery |
01/17/2012 | CA2320371C Inotropic and diuretic effects of exendin and glp-1 |
01/12/2012 | WO2012006612A2 Use of trans-palmitoleate in identifying and treating metabolic disease |
01/12/2012 | WO2012006598A2 Stabilized insulinotropic peptides and methods of use |
01/12/2012 | WO2012006512A1 Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease |
01/12/2012 | WO2012006500A2 Monoclonal antibodies against hepatitis c virus core protein |
01/12/2012 | WO2012006398A2 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
01/12/2012 | WO2012006027A1 Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules and treatments using same |
01/12/2012 | WO2012006014A2 Multi-component pharmaceuticals for treating diabetes |
01/12/2012 | WO2012005536A2 Pharmaceutical compositions including carbamoyloxy arylalkanoyl arylpiperazine compound |
01/12/2012 | WO2012005343A1 Substituted pyridine compound |
01/12/2012 | WO2012005340A1 Tablet containing ferric citrate |
01/12/2012 | WO2012005339A1 Prophylactic or therapeutic agent for diabetes |
01/12/2012 | WO2012004900A1 Thienopyrimidine compounds |
01/12/2012 | WO2012004773A1 New uses of nogo-a inhibitors and related methods |
01/12/2012 | WO2012004653A1 Method for inhibition of nf-kb gene expression |
01/12/2012 | WO2012004620A2 Use of deuterium depleted water for the treatment of insulin resistance |
01/12/2012 | WO2012004273A2 Array of age-tailored nutritional formula with optimum fat content |
01/12/2012 | WO2012004269A1 (2-aryloxy-acetylamino)-phenyl-propionic acid derivatives, method for producing same and use thereof as pharmaceuticals |
01/12/2012 | WO2012003811A1 C-aryl glucoside sglt2 inhibitors and method |
01/12/2012 | WO2012003784A1 Pyrazine derivatives,process for manufacture and use thereof |
01/12/2012 | WO2012003768A1 Semen cassiae soft capsule for reducing fat and losing weight and preparation method thereof |
01/12/2012 | WO2012003737A1 Method for preparing animal semen freeze-dried powder |
01/12/2012 | WO2012003576A1 Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
01/12/2012 | WO2012003554A2 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
01/12/2012 | WO2011118953A3 Composition for the prevention or treatment of obesity or lipid related metabolic deseases |
01/12/2012 | US20120010295 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
01/12/2012 | US20120010290 Methods of Treating an Overweight or Obese Subject |
01/12/2012 | US20120010287 N, n -dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same |
01/12/2012 | US20120010285 Agent for promoting energy consumption |
01/12/2012 | US20120010282 Tautomycetin and Tautomycetin Analog Biosynthesis |
01/12/2012 | US20120010265 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
01/12/2012 | US20120010262 Crystalline polymorphic forms of an antidiabetic compound |